Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by canadapieton Feb 10, 2020 11:32am
70 Views
Post# 30667935

RE:RE:RE:RE:Back to the MGH/DrG announcement

RE:RE:RE:RE:Back to the MGH/DrG announcementI totally agree with mr. Wino115!
That was my understanding too when i talked to mr. T. in december. The
FDA is not waiting 8 months to give an answer, but the whole proces
(questions/answers) could eventualy take that time, therefore he said end 
of 1H !!

Hope to get some clarifications when talking to him again (somewhere 
next week).

In the meantime, down down......:-(



Wino115
 - (2/10/2020 9:58:27 AM) 
RE:RE:RE:Back to the MGH/DrG announcement
Yes, is my guess. I think there is probably some gray area in relation to what is considered material for a proposed FDA meeting.  As was shown with Spectral down below in a message, they felt that just having the meeting and getting feedback was material.  Others may wait until the actual next step is needed, so having the meeting, reviewing the suggestions, answering the lingering questions and re-proposing the trial steps with the suggstions or counter-proposals and getting the actual OK.  Then they announce the FDA consultation is over.  You could probably argue both sides.  Knowing THTX, they'll wait for the actual endpoint so it can be fully buttoned up with no questions asked.  I can understand that. Just announcing they had the meeting would mean millions of questions on what the comments were, etc.. Until those are all answered you would leave the market with even more uncertainty and questions.  It really wouldn't help I don't think.  

To come out once done with the full FDA discussions and say 1) We have taken all FDA suggestions on board.  2) Here's out trial design - size, time, cost estimate 3) Here's what we want to prove for both NAFLD and for NASH.   Then it's fully nailed down.  They'd have to do the same with EMA.  They probably won't know full cost until EMA also agrees, so you may not get that estimate until the very end.  But size-wise, I can't see them asking for a huge sample given the massively smaller universe as the starting point. 300-400 should provided statisticallly meaningful results even with the normal drop-outs and placebo sleeve.  

But I guess my point is there is a wide interpretation of what legally needs to be announced as material. Some things are very clearly 100% material, some you can wait for clarification and finality.  That's what they're doing.
Bullboard Posts